Browse > Article

Negative regulators in RANKL-induced osteoclastogenesis  

Lee, Jun-Won (Medical Research Center for Gene Regulation, Chonnam National University Medical School)
Kim, Kab-Sun (Medical Research Center for Gene Regulation, Chonnam National University Medical School)
Kim, Nack-Sung (Medical Research Center for Gene Regulation, Chonnam National University Medical School)
Publication Information
International Journal of Oral Biology / v.32, no.1, 2007 , pp. 1-5 More about this Journal
Abstract
Receptor activator of nuclear factor ${\kappa}B$ ligand (RANKL) induces osteoclast formation from hematopoietic cells via up-regulation of positive regulators, including $NF-{\kappa}B$, c-Fos, microphthalmia transcription factor (Mitf), PU.1, and nuclear factor of activated T cells (NFAT) c1. In addition to the positive regulation by these transcription factors, RANKL appears to regulate negative regulators such as MafB and inhibitors of differentiation (Ids). Ids and MafB are abundantly expressed in osteoclast precursors, bone marrowderived monocyte/macrophage lineage cells (BMMs). Expression levels of these genes are significantly reduced by RANKL during osteoclastogenesis. Overexpression of these genes in BMMs inhibits the formation of tartarate-resistant acid phosphatase (TRAP)-positive multinuclear osteoclasts by down-regulation of NFATc1 and osteoclast-associated receptor (OSCAR), which are important for osteoclast differentiation. Furthermore, reduced expression of these genes enhances osteoclastogenesis and increases expression of NFATc1 and OSCAR. Taken together, RANKL induces osteoclastogenesis via up-regulation of positive regulators as well as down-regulation of negative regulators.
Keywords
osteoclasts; negative regulation; transcription factor; Id; MafB;
Citations & Related Records
연도 인용수 순위
  • Reference
1 EICHMANN, A., GRAPIN-BOTTON, A., KELLY, L., GRAF, T., LE DOUARIN, N. M. and SIEWEKE, M. The expression pattern of the mafB/kr gene in birds and mice reveals that the kreisler phenotype does not represent a null mutant. Mech Dev. 65:111-22, 1997   DOI   ScienceOn
2 ISHIKAWA, S., ARASE, N., SUENAGA, T., SAITA, Y., NODA, M., KURIYAMA, T., ARASE, H. and SAITO, T. Involvement of FcRgamma in signal transduction of osteoclast-associated receptor (OSCAR). Int Immunol. 16: 1019-25, 2004   DOI   ScienceOn
3 KELLY, L. M., ENGLMEIER, U., LAFON, I., SIEWEKE, M. H. and GRAF, T. MafB is an inducer of monocytic differentiation. Embo J. 19:1987-97, 2000   DOI   ScienceOn
4 KIM, K., KIM, J. H., LEE, J., JIN, H. M., LEE, S. H., FISHER, D. E., KOOK, H., KIM, K. K., CHOI, Y. and KIM, N. Nuclear factor of activated T cells c1 induces osteoclastassociated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis. J Biol Chem. 280:35209-16, 2005   DOI   ScienceOn
5 LACEY, D. L., TIMMS, E., TAN, H. L., KELLEY, M. J., DUNSTAN, C. R., BURGESS, T., ELLIOTT, R., COLOMBERO, A., ELLIOTT, G., SCULLY, S., HSU, H., SULLIVAN, J., HAWKINS, N., DAVY, E., CAPPARELLI, C., ELI, A., QIAN, Y. X., KAUFMAN, S., SAROSI, I., SHALHOUB, V., SENALDI, G., GUO, J., DELANEY, J. and BOYLE, W. J. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93: 165-76, 1998   DOI   ScienceOn
6 LEE, Z. H. and KIM, H. H. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem Biophys Res Commun. 305:211-4, 2003   DOI   ScienceOn
7 LUCHIN, A., SUCHTING, S., MERSON, T., ROSOL, T. J., HUME, D. A., CASSADY, A. I. and OSTROWSKI, M. C. Genetic and physical interactions between Microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation. J Biol Chem. 276: 36703-10, 2001   DOI   ScienceOn
8 TAKAYANAGI, H., KIM, S., KOGA, T., NISHINA, H., ISSHIKI, M., YOSHIDA, H., SAIURA, A., ISOBE, M., YOKOCHI, T., INOUE, J., WAGNER, E. F., MAK, T. W., KODAMA, T. and TANIGUCHI, T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 3:889-901, 2002   DOI   ScienceOn
9 YASUDA, H., SHIMA, N., NAKAGAWA, N., YAMAGUCHI, K., KINOSAKI, M., MOCHIZUKI, S., TOMOYASU, A., YANO, K., GOTO, M., MURAKAMI, A., TSUDA, E., MORINAGA, T., HIGASHIO, K., UDAGAWA, N., TAKAHASHI, N. and SUDA, T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesisinhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A. 95:3597-602, 1998
10 ASAGIRI, M., SATO, K., USAMI, T., OCHI, S., NISHINA, H., YOSHIDA, H., MORITA, I., WAGNER, E. F., MAK, T. W., SERFLING, E. and TAKAYANAGI, H. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J Exp Med. 202:1261-9, 2005   DOI   ScienceOn
11 BLANK, V. and ANDREWS, N. C. The Maf transcription factors: regulators of differentiation. Trends Biochem Sci. 22:437-41, 1997   DOI   ScienceOn
12 BOYLE, W. J., SIMONET, W. S. and LACEY, D. L. Osteoclast differentiation and activation. Nature. 423:337-42, 2003   DOI   ScienceOn
13 LEE, J., KIM, K., KIM, J. H., JIN, H. M., CHOI, H. K., LEE, S. H., KOOK, H., KIM, K. K., YOKOTA, Y., LEE, S. Y., CHOI, Y. and KIM, N. Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation. Blood. 107:2686-93, 2006   DOI   ScienceOn
14 KIM, Y., SATO, K., ASAGIRI, M., MORITA, I., SOMA, K. and TAKAYANAGI, H. Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis. J Biol Chem. 280:32905-13, 2005   DOI   ScienceOn
15 MOTOHASHI, H., SHAVIT, J. A., IGARASHI, K., YAMAMOTO, M. and ENGEL, J. D. The world according to Maf. Nucleic Acids Res. 25:2953-59, 1997   DOI
16 HODGKINSON, C. A., MOORE, K. J., NAKAYAMA, A., STEINGRIMSSON, E., COPELAND, N. G., JENKINS, N. A. and ARNHEITER, H. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell. 74: 395-404, 1993   DOI   ScienceOn
17 KIM, N., TAKAMI, M., RHO, J., JOSIEN, R. and CHOI, Y. A novel member of the leukocyte receptor complex regulates osteoclast differentiation. J Exp Med. 195:201-9, 2002   DOI
18 SO, H., RHO, J., JEONG, D., PARK, R., FISHER, D. E., OSTROWSKI, M. C., CHOI, Y. and KIM, N. Microphthalmia transcription factor and PU.1 synergistically induce the leukocyte receptor osteoclast-associated receptor gene expression. J Biol Chem. 278:24209-16, 2003   DOI   ScienceOn
19 WONG, B. R., RHO, J., ARRON, J., ROBINSON, E., ORLINICK, J., CHAO, M., KALACHIKOV, S., CAYANI, E., BARTLETT, F. S., 3RD, FRANKEL, W. N., LEE, S. Y. and CHOI, Y. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun Nterminal kinase in T cells. J Biol Chem. 272:25190-4, 1997   DOI   ScienceOn
20 IOTSOVA, V., CAAMANO, J., LOY, J., YANG, Y., LEWIN, A. and BRAVO, R. Osteopetrosis in mice lacking NFkappaB1 and NF-kappaB2. Nat Med. 3:1285-9, 1997   DOI   ScienceOn
21 TEITELBAUM, S. L. Bone resorption by osteoclasts. Science. 289:1504-8, 2000   DOI   ScienceOn
22 LASORELLA, A., UO, T. and IAVARONE, A. Id proteins at the cross-road of development and cancer. Oncogene. 20:8326-33, 2001   DOI
23 MOCSAI, A., HUMPHREY, M. B., VAN ZIFFLE, J. A., HU, Y., BURGHARDT, A., SPUSTA, S. C., MAJUMDAR, S., LANIER, L. L., LOWELL, C. A. and NAKAMURA, M. C. The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci U S A. 101:6158-63, 2004
24 WANG, Z. Q., OVITT, C., GRIGORIADIS, A. E., MOHLESTEINLEIN, U., RUTHER, U. and WAGNER, E. F. Bone and haematopoietic defects in mice lacking c-fos. Nature. 360:741-5, 1992   DOI   ScienceOn
25 KIM, K., KIM, J. H., LEE, J., JIN, H. M., KOOK, H., KIM, K. K., LEE, S. Y. and KIM, N. MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood. DOI 10.1182/blood-2006-09-048249, 2007
26 HIROTANI, H., TUOHY, N. A., WOO, J. T., STERN, P. H. and CLIPSTONE, N. A. The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells. J Biol Chem. 279:13984-92, 2004   DOI   ScienceOn
27 SIMON, M. C. PU.1 and hematopoiesis: lessons learned from gene targeting experiments. Semin Immunol. 10:111-8, 1998   DOI   ScienceOn
28 CORDES, S. P. and BARSH, G. S. The mouse segmentation gene kr encodes a novel basic domain-leucine zipper transcription factor. Cell. 79:1025-34, 1994   DOI   ScienceOn
29 SIEWEKE, M. H., TEKOTTE, H., FRAMPTON, J. and GRAF, T. MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiation. Cell. 85:49-60, 1996   DOI   ScienceOn
30 ANDERSON, D. M., MARASKOVSKY, E., BILLINGSLEY, W. L., DOUGALL, W. C., TOMETSKO, M. E., ROUX, E. R., TEEPE, M. C., DUBOSE, R. F., COSMAN, D. and GALIBERT, L. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 390:175-9, 1997   DOI   ScienceOn
31 TAKAYANAGI, H. Mechanistic insight into osteoclast differentiation in osteoimmunology. J Mol Med. 83:170-9, 2005   DOI
32 MOTYCKOVA, G., WEILBAECHER, K. N., HORSTMANN, M., RIEMAN, D. J., FISHER, D. Z. and FISHER, D. E. Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family. Proc Natl Acad Sci U S A. 98:5798-803, 2001
33 SINGH, H., DEKOTER, R. P. and WALSH, J. C. PU.1, a shared transcriptional regulator of lymphoid and myeloid cell fates. Cold Spring Harb Symp Quant Biol. 64:13-20, 1999
34 KOGA, T., INUI, M., INOUE, K., KIM, S., SUEMATSU, A., KOBAYASHI, E., IWATA, T., OHNISHI, H., MATOZAKI, T., KODAMA, T., TANIGUCHI, T., TAKAYANAGI, H. and TAKAI, T. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature. 428:758-63, 2004   DOI   ScienceOn
35 MANSKY, K. C., SANKAR, U., HAN, J. and OSTROWSKI, M. C. Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NFkappa B ligand signaling. J Biol Chem. 277:11077-83, 2002   DOI   ScienceOn
36 MERCK, E., GAILLARD, C., GORMAN, D. M., MONTEROJULIAN, F., DURAND, I., ZURAWSKI, S. M., MENETRIERCAUX, C., CARRA, G., LEBECQUE, S., TRINCHIERI, G. and BATES, E. E. OSCAR is an FcRgamma-associated receptor that is expressed by myeloid cells and is involved in antigen presentation and activation of human dendritic cells. Blood. 104:1386-95, 2004   DOI   ScienceOn
37 SUDA, T., TAKAHASHI, N., UDAGAWA, N., JIMI, E., GILLESPIE, M. T. and MARTIN, T. J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev. 20:345-57, 1999   DOI   ScienceOn
38 BENEZRA, R., DAVIS, R. L., LOCKSHON, D., TURNER, D. L. and WEINTRAUB, H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell. 61:49-59, 1990   DOI   ScienceOn
39 TEITELBAUM, S. L. and ROSS, F. P. Genetic regulation of osteoclast development and function. Nat Rev Genet. 4: 638-49, 2003   DOI   ScienceOn
40 MASSARI, M. E. and MURRE, C. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol. 20:429-40, 2000   DOI
41 WAGNER, E. F. and EFERL, R. Fos/AP-1 proteins in bone and the immune system. Immunol Rev. 208:126-40, 2005   DOI   ScienceOn
42 LUCHIN, A., PURDOM, G., MURPHY, K., CLARK, M. Y., ANGEL, N., CASSADY, A. I., HUME, D. A. and OSTROWSKI, M. C. The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts. J Bone Miner Res. 15:451-60, 2000   DOI